ArthroCare Reports Q4 EPS of $0.30

ArthroCare (NASDAQ: ARTC) reports its Q4 EPS at $0.30, versus the consensus of $0.28. ARTC reports its Q4 revenue at $92.6 million, versus the consensus of $89.38 million. ARTC shares fell 0.45% to close at $31.15 on Friday. Read more from Benzinga's Company news.